News
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or overweight.
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...
The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...
Explore more
1d
News-Medical.Net on MSNWhich GLP-1 meds have the most side effects? Study of 60,000 Facebook posts gives answersResearchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...
* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...
Comedian and Emmy-nominated actor Kym Whitley opens up about her long journey with weight management. The "Happy Gilmore 2" ...
Hosted on MSN20d
Tirzepatide reduces food intake and appetite, and affects brain functioning, more than placebo and liraglutideResearchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results